참고문헌
- Bhoo Pathy N, Yip CH, ONE AUTHOR, et al (2011). Breast cancer in a multi-ethnic Asian setting: Results from the Singapore-Malaysia hospital-based breast cancer registry. Breast.??
- Chow LW, Ho P (2000). Hormonal receptor determination of 1,052 Chinese breast cancers. J Surg Oncol, 75, 172-5. https://doi.org/10.1002/1096-9098(200011)75:3<172::AID-JSO4>3.0.CO;2-A
- De Maeyer L, Van Limbergen E, ONE AUTHOR, et al (2008). Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?" J Clin Oncol, 26, 335-6 https://doi.org/10.1200/JCO.2007.14.8411
- Dunnwald LK, Rossing MA, ONE AUTHOR, et al (2007). Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients." Breast Cancer Res, 9, 6-?. https://doi.org/10.1186/bcr1639
- Nadji M (2008). Quantitative immunohistochemistry of estrogen receptor in breast cancer: "much ado about nothing!". Appl Immunohistochem Mol Morphol, 16, 105-7. https://doi.org/10.1097/PAI.0b013e3181607323
- Nadji M, C Gomez-Fernandez, ONE AUTHOR, et al (2005)."Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers." Am J Clin Pathol, 123, 21-7. https://doi.org/10.1309/4WV79N2GHJ3X1841
- Rakha E A, El-Sayed ME, ONE AUTHOR, et al (2007). Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. J Clin Oncol, 25, 4772-8. https://doi.org/10.1200/JCO.2007.12.2747
- Rakha EA, Reis-Filho JS, ONE AUTHOR, et al (2010). Combinatorial biomarker expression in breast cancer. Breast Cancer Res, 120, 293-308. https://doi.org/10.1007/s10549-010-0746-x
- Rhodes, Jasani AB (2009). The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact? J Clin Pathol, 62, 95-6.
- Rhodes, Jasani AB, ONE AUTHOR, et al (2000). Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J Clin Pathol, 53, 688-96. https://doi.org/10.1136/jcp.53.9.688
- Yip CH (2009). Breast cancer in Asia. Methods Mol Biol, 471, 51-64. https://doi.org/10.1007/978-1-59745-416-2_3
피인용 문헌
- Do Clinical Features and Survival of Single Hormone Receptor Positive Breast Cancers Differ from Double Hormone Receptor Positive Breast Cancers? vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7959
- Heterogeneity of Breast Cancer Clinical Characteristics and Outcome in US Black Women-Effect of Place of Birth vol.20, pp.5, 2014, https://doi.org/10.1111/tbj.12302
- Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers vol.2014, pp.1687-8566, 2014, https://doi.org/10.1155/2014/469251
- Higher miR-21 expression in invasive breast carcinomas is associated with positive estrogen and progesterone receptor status in patients from Serbia vol.31, pp.6, 2014, https://doi.org/10.1007/s12032-014-0977-5
- Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer vol.10, pp.7, 2015, https://doi.org/10.1371/journal.pone.0132449
- Expression of estrogen and progesterone receptors across human malignancies: new therapeutic opportunities vol.34, pp.4, 2015, https://doi.org/10.1007/s10555-014-9543-z
- Re-Appraisal of Estrogen Receptor Negative/Progesterone Receptor Positive (ER−/PR+) Breast Cancer Phenotype: True Subtype or Technical Artefact? pp.1532-2807, 2017, https://doi.org/10.1007/s12253-017-0304-5
- Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer vol.73, pp.4, 2018, https://doi.org/10.1111/his.13523